Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
Authors
Keywords
-
Journal
Lancet Respiratory Medicine
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-04-19
DOI
10.1016/s2213-2600(21)00097-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biologics for chronic rhinosinusitis with nasal polyps
- (2020) Claus Bachert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
- (2020) Valerie Hox et al. Clinical and Translational Allergy
- Real‐life assessment of chronic rhinosinusitis patients using mobile technology: the mySinusitisCoach project by EUFOREA
- (2020) Sven F. Seys et al. ALLERGY
- Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials
- (2020) Philippe Gevaert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effect of short-course glucocorticoid application on patients with chronic rhinosinusitis with nasal polyps
- (2020) Zhaofeng Xu et al. World Allergy Organization Journal
- EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management
- (2020) Claus Bachert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Chronic Rhinosinusitis with Nasal Polyps
- (2019) Claire Hopkins NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
- (2019) Claus Bachert et al. LANCET
- Strategies for composite estimands in confirmatory clinical trials: Examples from trials in nasal polyps and steroid reduction
- (2018) Oliver N. Keene PHARMACEUTICAL STATISTICS
- Management strategies for chronic rhinosinusitis: a qualitative study of GP and ENT specialist views of current practice in the UK
- (2018) Jane Vennik et al. BMJ Open
- Biomarkers for severe eosinophilic asthma
- (2017) Steven W. Yancey et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
- (2017) Claus Bachert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Missing data in clinical trials: control-based mean imputation and sensitivity analysis
- (2017) Devan V. Mehrotra et al. PHARMACEUTICAL STATISTICS
- Investigating the minimal clinically important difference for SNOT-22 symptom domains in surgically managed chronic rhinosinusitis
- (2017) Naweed I. Chowdhury et al. International Forum of Allergy & Rhinology
- Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
- (2017) Geoffrey L Chupp et al. Lancet Respiratory Medicine
- Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre
- (2016) J. van der Veen et al. ALLERGY
- The prevalence of olfactory dysfunction in chronic rhinosinusitis
- (2016) Preeti Kohli et al. LARYNGOSCOPE
- Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis
- (2016) Adam S. DeConde et al. LARYNGOSCOPE
- Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies
- (2016) Hector G Ortega et al. Lancet Respiratory Medicine
- Altered Quality of Life and Psychological Health (SCL-90-R) in Patients With Chronic Rhinosinusitis With Nasal Polyps
- (2015) Jae Ho Chung et al. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
- Characterization of the relationship between dose and blood eosinophil response following subcutaneous administration of mepolizumab
- (2015) Isabelle J. Pouliquen et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Can surgeons predict the olfactory outcomes after endoscopic surgery for nasal polyposis?
- (2015) Duc Trung Nguyen et al. LARYNGOSCOPE
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis
- (2011) Philippe Gevaert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Correlations between symptoms, nasal endoscopy, and in-office computed tomography in post-surgical chronic rhinosinusitis patients
- (2011) William R. Ryan et al. LARYNGOSCOPE
- Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma
- (2010) Claus Bachert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More